KPF
ABVX

K2 Principal Fund’s Abivax ABVX Stock Holding History

K2 Principal Fund’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
85,100
+75,100
+751% +$8.5M 0.83% 30
2026
Q1 		$1.11M Hold
10,000
– – 0.08% 243
2025
Q4 		$1.35M Buy
+10,000
New +$1.09M 0.11% 189

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

K2 Principal Fund's ABVX Position: Q2 2026 in Review

K2 Principal Fund reduced its Abivax (ABVX) stake by 55% in Q2 2026, selling an estimated $3.32M and leaving 24,403 shares worth $3.25M. The position accounts for 0.24% of the portfolio, ranked #122.

K2 Principal Fund first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.98M in Q1 2026. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • K2 Principal Fund held 24,403 shares of Abivax worth $3.25M as of Q2 2026.
  • K2 Principal Fund sold 29,338 Abivax shares in Q2 2026, an estimated $3.32M.
  • Abivax made up 0.24% of K2 Principal Fund's portfolio in Q2 2026, its #122 holding.
  • K2 Principal Fund first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • K2 Principal Fund's Abivax position peaked at $5.98M in Q1 2026.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.